Gamma Investing LLC Biogen Inc. Transaction History
Gamma Investing LLC
- $1.81 Trillion
- Q3 2025
A detailed history of Gamma Investing LLC transactions in Biogen Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 4,343 shares of BIIB stock, worth $669,039. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,343
Previous 3,587
21.08%
Holding current value
$669,039
Previous $450 Million
35.05%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding BIIB
# of Institutions
1,021Shares Held
131MCall Options Held
2.87MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.66 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.43 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.24 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.15 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$739 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...